Live Breaking News & Updates on Arthur Weber Prize

Stay updated with breaking news from Arthur weber prize. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Cardiol Therapeutics Announcements | Cardiol Therapeutics: Original-Research: Cardiol Therapeutics (von GBC AG):

Analyst: Julien Desrosiers; Felix Haugg
The Company announced topline results from its Phase I Single and Multiple
Ascending Dose Clinical Trial of CardiolRx(TM). CardiolRx is a
pharmaceutically produced oral cannabidiol formulation being developed for
the treatment of acute and chronic inflammation associated with heart
disease. These results positively support Cardiol Therapeutics proposed
treatment dosage for their upcoming CardiolRx Phase II and Phase II/III
trials. David Elsley, President and CEO of Cardiol Therapeutics, stated:
Cardiol is initiating a Phase II/III clinical trial in the U.S.
investigating the cardioprotective properties of CardiolRx in 422
hospitalized patients with COVID-19 with a prior history of, or risk ....

United States , Julien Desrosiers , Felix Haugg , Carsten Tsch , David Elsley , Matthias Friedrich , Mcgill University Hospital , Department Of Internal Medicine , Company Phase , Steering Committee , University Medicine Berlin , Gw Pharmaceuticals , University Hospital , German Cardiac Society , Cardiol Therapeutics , Management Interview Letzte Rating , Phasei Single , Multiple Ascending Dose Clinical Trial , Cardiol Therapeutic , Cardiolrx Phase , Investigational New Drug , Jazz Pharmaceutical , Vice Director , Internal Medicine , Arthur Weber Prize , Cardiovascular Magnetic Resonance ,